BRITTNEY HENSLEY: Open Payments
NPI 1912445628 · SHERIDAN, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$423 in 24 payments from 11 companies in 2025. Trend: 2023 $444 · 2024 $449 · 2025 $423
Food & beverage: $423
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 6 | $107 |
| AstraZeneca Pharmaceuticals LP | 5 | $87 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $68 |
| Novo Nordisk Inc | 2 | $34 |
| Lilly USA, LLC | 2 | $28 |
| Globus Medical, Inc. | 1 | $22 |
| Sumitomo Pharma America, Inc. | 1 | $18 |
| PFIZER INC. | 1 | $16 |
| Exact Sciences Corporation | 1 | $15 |
| GlaxoSmithKline, LLC. | 1 | $15 |
Products named: UBRELVY, CAPLYTA, AIRSUPRA, BREZTRI, VRAYLAR, Senza, GEMTESA, Rybelsus.
Industry payments across AR — which companies pay providers there.
